옵션 체인은 다양한 행사가격과 만기일에 대한 Axos Financial의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Axos Financial에 대한 시장 심리를 평가합니다..

Axos Financial (NYSE:AX) 주식, 옵션 체인

Axos Financial

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment . The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

Axos Financial Inc

HSBC BANK 13/11/24 WNT

AXIOS SUSTANBLE GRWTH A by AXIOS Sustainable Growth Acquisition Corporation

AXIOS Sustainable Growth Acquisition Corp

AXA SA

AXA ORD

Abraxas Petroleum Corp

AXIS BANK GDR

AXIS BANK 144A GDR

AXIS BANK LTD S/GDR 144A by Axis Bank Ltd.

Axis Bank Ltd

AXIOS MOBILE ASSETS ORD by Axios Mobile Assets Corp.

EYES ON THE GO INC by Eyes on the Go, Inc.

Eyes on the Go Inc

ALLIXON INTL CORP by Allixon International Corp.

Allixon International Corp

AZUCAR MINERALS LTD by Azucar Minerals Ltd.

Azucar Minerals Ltd

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics Inc

ISH ACTAXEE ETF

AXEL

Axfood AB

AXIS ENERGY CORP by Axis Energy Corporation

Axis Energy Corp

Accent Group Ltd

Axogen Inc

ALEXIUM INTL GRP LTD ORD by Alexium International Group Ltd.

Alexium International Group Ltd

AXIL Brands Inc

AXIM BIOTECHNOLOGIES INC by Axim Biotechnologies, Inc.

AXIM Biotechnologies Inc

AXIS Token

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Holdings Inc

Axelar - United States Dollar

Axiologix Inc

AXMIN Inc

AXM PHARMA INC by AXM Pharma, Inc.

ALLIANCE NICKEL LTD by ALLIANCE NICKEL LTD

Alliance Nickel Ltd

AXION VENTURES INC by Axion Ventures Inc.

Axion Ventures Inc

Axonics Inc

Axon Enterprise Inc

American Express Co

AXPR

AXIS PETROLEUM CO CAP by Axis Petroleum Co.

AXION POWER INTL INC by Axion Power International, Inc.

Axion Power International Inc

AMERICAN EXPRESS ORD

Amrep Corp

AMARC RESOURCE LTD by Amarc Resources Ltd.

Amarc Resources Ltd

Amexdrug Corp

Axis Capital Holdings Limited Common Stock

Axis Capital Holdings Ltd

Axie Infinity - United States Dollar

Axsome Therapeutics Inc

Axis Capital Holdings Limited Depositary Shares, each representing 1/100th interest in a share of a 5.50% Series E Preferred Shares

Axalta Coating Systems Ltd. Common Shares

Axalta Coating Systems Ltd

AXALTA COATING SYSTEMS ORD

AXIS TECHS GROUP INC by Axis Technologies Group, Inc.

Axis Technologies Group Inc

AXT Inc

AXTEL SAB DE CV B by Axtel S. A.. B. De CV

Axtel SAB de CV

CDN MAVERICK CAP CORP by CDN MAVERICK CAP CORP.

CDN Maverick Capital Corp

Exxe Group Inc

ALDERON IRON ORE CORP by Alderon Iron Ore Corp.

Alderon Iron Ore Corp

Axiata Group Bhd

WIIM

Dynatrace shares are trading lower. The company reported Q2 financial results.

XOMA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>) reported quarterly losses of $(1.59) per share which missed the analyst consensus estimate of $(0.44) by 261.36 percent. The company reported quarterly sales of $9.197 million which beat the analyst consensus estimate of $6.493 million by 41.65 percent. This is a 1.01K percent increase over sales of $830.000 thousand the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

XOMA

XOMA Q3 2024 GAAP EPS $(1.59) Misses $(0.44) Estimate, Sales $9.197M Beat $6.493M Estimate

Trevena (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) reported quarterly losses of $(5.79) per share which beat the analyst consensus estimate of $(7.38) by 21.54 percent. The company reported $283.00 in sales this quarter. This is a 99.84 percent decrease over sales of $180.00 thousand the same period last year.

TRVN

Trevena Q3 2024 GAAP EPS $(5.79) Beats $(7.38) Estimate, Sales $283.00 Down From $180.00K YoY

The transaction is part of the objective UScellular announced on May 28, 2024, to opportunistically monetize the spectrum that was not included in the proposed sale to T-Mobile; and follows the transactions previously announced on October 18, 2024, to sell a portion of the retained spectrum licenses to Verizon and two other mobile network operators.
Following this transaction, as well as those previously announced, UScellular will have reached definitive agreements to monetize approximately 55%, measured on a MHz-Pops basis, of the spectrum holdings (excluding mmWave) that were excluded from the proposed sale to T-Mobile, for a total consideration of approximately $2.02 billion. &nbsp;

Asset Sales

United States Cellular Enters Agreement With AT&T To Sell Portion Of Its Retained Spectrum Licenses For Total Consideration Of $1.018B

CORRECTION: BCE Q3 2024 Adj. EPS CAD0.75 Misses CAD0.77 Estimate, Sales CAD5.971B Miss CAD6.032B Estimate

UBS analyst Steven Fisher initiates coverage on Martin Marietta Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLM#NYSE">MLM</a>) with a Buy rating and announces Price Target of $730.

Price Target

Initiation

Analyst Ratings

UBS Initiates Coverage On Martin Marietta Materials with Buy Rating, Announces Price Target of $730

Management

EHAB

Enhabit Home Health & Hospice Appoints Ryan Solomon As CFO, Effective Dec. 9

Needham analyst Bernie McTernan reiterates Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) with a Hold.

Reiteration

Needham Reiterates Hold on Zillow Gr

Dividends

Fidelity National Financial Increases Dividend From $0.48 To $0.50/Share

F&G Annuities & Life Increases Quarterly Dividend From $0.21 To $0.22/Share

Fiscal 2024 Outlook
Thilo Wrede, Vital Farms' Chief Financial Officer, commented: "With another solid performance in the third quarter, I am pleased to again update our guidance for 2024. Our new outlook reflects the strong performance of the business for the first nine months of this year and our good visibility for the fourth quarter of 2024. Our revised guidance is built around a favorable commodity outlook and strong consumer demand supported by our marketing reinvestment strategy. Vital Farms' long-term strategy is built to increase brand awareness, drive deeper loyalty with consumers, and grow our household penetration through focused energies on brand marketing and continuous retail expansion."
For the fiscal year 2024, management now expects:
<ul>
<li>Net revenue of at least $600 million, which represents at least 27% growth versus fiscal year 2023, compared to our previous expectation of at least $590 million, or 25% growth.</li>
<li>Adjusted EBITDA of at least $80 million, which represents at least 65% growth versus fiscal year 2023, compared to our previous expectation of at least $75 million, or 55% growth.</li>
<li>Capital expenditures for the full year in the range of $30 million to $40 million, which is reduced from our previous range of $35 million to $45 million due to updated timing on some key projects. We continue to evaluate our capital allocation priorities, and we will provide updates as necessary in future earnings reports. &nbsp;</li>
</ul>
Vital Farms' guidance includes the effect of lapping an extra shipping week in Q4 2023 and assumes that there are no significant disruptions to the supply chain or its customers or consumers, including any issues from adverse macroeconomic factors. Vital Farms cannot provide a reconciliation between its forecasted Adjusted EBITDA and net income and Adjusted EBITDA Margin and net income margin, their most directly comparable GAAP measures, without unreasonable effort due to the unavailability of reliable estimates for income taxes, among other items. These items are not within our control and may vary greatly between periods and could significantly impact future financial results.

Guidance

VITL

Vital Farms Sees FY24 Revenue Of At least $600M Vs $598.35M Est.

Z: 15% &#x7C; <a href="https://www.benzinga.com//node/41803768">Zillow Group shares are trading higher after the company reported better-than-expected Q3 financial results.</a>
&nbsp;
APP: 32% &#x7C; <a href="https://www.benzinga.com//node/41803196">Applovin shares are trading higher after the company reported better-than-expected Q3 financial results.</a>
&nbsp;
CYN: 63% &#x7C; <a href="https://www.benzinga.com//node/41803438">Cyngn Announced Progress Of Its Proprietary Computer Vision Technology For Industrial Autonomous Machines, Built On Nvidia Accelerated Computing</a>

Movers

Trading Ideas

Market-Moving News for November 7th

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Alector (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALEC#NASDAQ">ALEC</a>) with a Buy and maintains $35 price target.

ALEC

HC Wainwright & Co. Reiterates Buy on Alector, Maintains $35 Price Target

Clear Channel Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCO#NYSE">CCO</a>) announced its Q3 earnings on Thursday, October 31, 2024 at 06:00 AM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Clear Channel Outdoor missed estimated earnings by 0.0%, reporting an EPS of $-0.06 versus an estimate of $-0.06.
Revenue was up $32.20 million from the same period last year.
<h3>Overview of Past Earnings</h3>
During the previous quarter, the company beat on EPS by $0.01, leading to a 3.0% drop share price change the next day.
Here's a look at Clear Channel Outdoor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.06</td>
<td>-0.05</td>
<td>-0.17</td>
<td>0.04</td>
<td>-0.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.06</td>
<td>-0.04</td>
<td>-0.17</td>
<td>0.05</td>
<td>-0.11</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>557.41M</td>
<td>562.37M</td>
<td>478.55M</td>
<td>610.14M</td>
<td>594.92M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>558.99M</td>
<td>558.54M</td>
<td>481.75M</td>
<td>632.11M</td>
<td>526.79M</td>
</tr>
</tbody>
</table>

<h3>Competitors that recently released earnings</h3>
When analyzing Clear Channel Outdoor's numbers, it's imperative to put them into context by comparing them to those of its competitors, like PubMatic, TechTarget, and National CineMedia.
<ul>
<li>PubMatic announced strong earnings on August 08, 2024, surpassing market expectations. Despite an estimated EPS of $-0.02, PubMatic's actual EPS was $0.17, reflecting a 950.0% increase.</li>
<li>TechTarget's earnings announcement on August 08, 2024 exceeded expectations, with an actual EPS of $0.42 compared to the market's projected EPS of $0.4, resulting in a 5.0% increase.</li>
<li>National CineMedia reported earnings on November 05, 2024 that fell short of expectations, with an actual EPS of $-0.04 compared to the market's estimate of $-0.03, resulting in a -33.33% decrease.</li>
</ul>
<h3>Insights into Competitors' Quarterly Earnings and Stock Performance</h3>
In this detailed analysis, insights are provided into the market's response to the latest earnings releases of key competitors. It highlights the expected and announced earnings per share (EPS) for each company, along with their corresponding stock prices at the close of the announcement day and the open of the following trading day.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Date</th>
<th style="text-align: right;">EPS Expected</th>
<th style="text-align: right;">EPS Announced</th>
<th>EPS Change Percent</th>
<th>Stock Price At Close</th>
<th>Stock Price at Next Day Open</th>
<th>Price Change Percent</th>
</tr>
</thead>
<tbody>
<tr>
<td>Clear Channel Outdoor</td>
<td>October 31, 2024</td>
<td style="text-align: right;">-0.06</td>
<td style="text-align: right;">-0.06</td>
<td>0.0%</td>
<td>$1.47</td>
<td>$1.48</td>
<td>0.68%</td>
</tr>
<tr>
<td>PubMatic</td>
<td>August 08, 2024</td>
<td style="text-align: right;">-0.02</td>
<td style="text-align: right;">0.17</td>
<td>950.0%</td>
<td>$19.6</td>
<td>$13.82</td>
<td>-29.49%</td>
</tr>
<tr>
<td>TechTarget</td>
<td>August 08, 2024</td>
<td style="text-align: right;">0.40</td>
<td style="text-align: right;">0.42</td>
<td>5.0%</td>
<td>$29.02</td>
<td>$28.38</td>
<td>-2.21%</td>
</tr>
<tr>
<td>National CineMedia</td>
<td>November 05, 2024</td>
<td style="text-align: right;">-0.03</td>
<td style="text-align: right;">-0.04</td>
<td>-33.33%</td>
<td>$7.3</td>
<td>$7.35</td>
<td>0.68%</td>
</tr>
</tbody>
</table>

<h3>Comparative Assessment: Estimated in Comparison with Actual Peer Revenues</h3>
The following table compares estimated and announced revenue figures for Clear Channel Outdoor's peers. This comparison provides insights into the revenue performance of these companies, offering valuable context to understand their financial standing within the industry.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Estimated Revenue</th>
<th>Announced Revenue</th>
<th>Revenue Surprise Percentage</th>
</tr>
</thead>
<tbody>
<tr>
<td>Clear Channel Outdoor</td>
<td>557.41M</td>
<td>558.99M</td>
<td>0.28%</td>
</tr>
<tr>
<td>PubMatic</td>
<td>70.12M</td>
<td>67.27M</td>
<td>-4.07%</td>
</tr>
<tr>
<td>TechTarget</td>
<td>58.08M</td>
<td>58.91M</td>
<td>1.44%</td>
</tr>
<tr>
<td>National CineMedia</td>
<td>58.02M</td>
<td>62.40M</td>
<td>7.55%</td>
</tr>
</tbody>
</table>

To track all earnings releases for Clear Channel Outdoor <a href="https://www.benzinga.com/quote/CCO/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Clear Channel Outdoor: Q3 Earnings Insights

Amylyx Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLX#NASDAQ">AMLX</a>) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.71) by 25.35 percent. The company reported $416.000 thousand in sales this quarter. This is a 99.59 percent decrease over sales of $102.693 million the same period last year.

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

Amylyx Pharma Q3 2024 Adj. EPS $(0.53) Beats $(0.71) Estimate, Sales $416.000K Down From $102.693M YoY

Jefferies analyst Julien Dumoulin-Smith initiates coverage on Edison Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) with a Buy rating and announces Price Target of $93.

Jefferies Initiates Coverage On Edison Intl with Buy Rating, Announces Price Target of $93

CING

Cingulate Q3 Net Loss $3.2M

Biotech

Health Care

General

CALC

CalciMedica Has Appointed Stephen Bardin As Chief Financial Officer And The Planned Departure Of Daniel Geffken, Interim Chief Financial Officer Upon Filing The Company's Third Quarter Financial Statements

Reaffirms Full Year 2024 Outlook on Key Metrics
The Company is reaffirming its full year 2024 outlook on Key Metrics:
<ul>
<li>Net sales to decrease low to high teens in percentage terms, tracking toward the middle of the range.</li>
<li>Adjusted EBITDA(1) that is positive.</li>
<li>Free Cash Flow(1) that is positive. &nbsp;</li>
</ul>
Hydrofarm's 2024 outlook also reaffirms the following assumptions:
<ul>
<li>Reduced year-over-year Adjusted SG&amp;A(1) expense resulting primarily from (i) full year benefit of headcount reductions completed in 2023 and (ii) reductions in professional fees, facilities and insurance expenses.</li>
<li>Reduction in inventory and net working capital helping to generate positive Free Cash Flow(1) for the full year.</li>
</ul>
Hydrofarm's 2024 outlook also includes the following updated assumptions:
<ul>
<li>Adjusted Gross Profit Margin(1) that is flat to slightly down compared to the prior year. This is an update to the prior expectation of a year-over-year improvement.</li>
<li>Capital expenditures of $2.5 million to $3.5 million, compared to the prior expectation of $3.5 million to $4.5 million.</li>
</ul>
(1) Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&amp;A, Adjusted SG&amp;A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For reconciliations of GAAP to non-GAAP measures see the "Reconciliation of Non-GAAP Measures" accompanying the release.

HYFM

Hydrofarm Sees FY24 Net Sales To Decrease Low To High Teens In Percentage Terms, Tracking Toward The Middle Of The Range

Wedbush analyst Nick Setyan reiterates Dine Brands Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIN#NYSE">DIN</a>) with a Outperform and maintains $47 price target.

Wedbush Reiterates Outperform on Dine Brands Global, Maintains $47 Price Target

Reports Q1 NII $292.05M, up 38.3% y/y. "Net interest income increased by 12.3% and 38.3% linked-quarter and year-over-year, respectively, driven by...

Axos Financial reports Q3 EPS $1.96, consensus $1.78

"Net interest income increased by 12.3% and 38.3% linked-quarter and year-over-year, respectively, driven by further expansion in our net interest ...

Axos Financial reports Q1 adjusted EPS $1.96, consensus $1.78

Axos Financial Non-GAAP EPS of $1.96 beats by $0.18, revenue of $320.66M beats by $22.03M

Axos Financial, Inc. (AX) Q1 2025 Earnings Call Transcript

Axos Financial, Inc. 2025 Q1 - Results - Earnings Call Presentation

Axos Financial ( ($AX) ) has realeased its Q1 earnings. Here is a breakdown of the information Axos Financial presented to its investors. Axos Fina...

Axos Financial Reports Strong Q1 2025 Earnings

Analyst Kyle Peterson of Needham reiterated a Buy rating on Axos Financial (AX – Research Report), boosting the price target to $85.00. Kyle Peters...

Axos Financial's Strong Q1 2025 Performance and Growth Prospects Lead to Buy Rating

Axos Clearing partners with Envestnet to deliver managed account solutions

Gator Capital Management Q3 2024 Investor Letter

Axos Financial ( ($AX) ) has provided an announcement. Axos Financial, Inc. is positioning itself as a formidable player in the financial markets w...

Comments

Axos Financial

Axos Financial (AX) 옵션

Axos Financial (NYSE:AX) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌